NCT Number: NCT00268281
Left Ventricular Capture Management (LVCM) Software Download Clinical Trial
Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. When there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed.
Left Ventricular Capture Management (LVCM) refers to the overall method for determining left ventricular thresholds (level of energy needed to effectively pace the tissue in the lower left chamber of the heart) by measuring, analyzing, and adjusting energy delivered from the CRT device to the pacing lead.
The purpose of the Left Ventricular Capture Management Software Download Clinical Trial was to evaluate the accuracy of the Left Ventricular Capture Management (LVCM) feature to support LVCM feature approval in future cardiac resynchronization therapy with defibrillation (CRT-D) devices
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Phoenix, Arizona, United States
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Subjects who successfully underwent implantation of an InSync II Marquis system
Exclusion criteria
- Subjects who are post-heart transplant
- Subjects enrolled in a concurrent study that may confound the results of this study
Treatment and study plan
Primary outcomes
-
To evaluate the accuracy of left ventricular capture management (LVCM)
Secondary outcomes
-
To compare left ventricular capture management (LVCM) measurements to a similar measurement taken automatically when subjects are completing normal daily activities
-
To evaluate subject rhythm and rate immediately following an LVCM measurements
-
To characterize all adverse events
Sponsors and collaborators
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure
Industry
Registry information
Important dates
- Study start
- 2004
- Study completion
- 2005
- First posted
- Dec 22, 2005
- Registry last updated
- Oct 13, 2006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Re-Prosper HF Study
NCT04551222
Cardiovascular Diseases, Heart Diseases
Boston, Massachusetts, United States
View Trial DetailsBlood Pressure Reduction in Patients With Asymptomatic Aortic VALVE Stenosis
NCT04613193
Aortic Valve Disease, Aortic Valve Stenosis
Aarhus, Denmark
View Trial DetailsBAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction
NCT02876042
Cardiovascular Diseases, Heart Diseases
Berlin, Germany
View Trial DetailsThe Impact of Video-based Cardiac Rehabilitation Education in Patients With CIEDs
NCT06503445
Arrhythmia, Arrhythmias, Cardiac
Hsinchu, Taiwan
View Trial Details